InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Schoeneck James A, 董事. Officer active across 2 companies, notably FIBROGEN INC. Cumulatively, 11 disclosures have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €311k. History available since 26 May 2021. The latest transaction was disclosed on 21 August 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Schoeneck James A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
75,000 股@ US$2.0040.5% 占其流量Common StockSEC:0001641172-25-025448:0
标准退出：2025年11月19日 (T+90)
23,567 股@ US$5.0755.7% 占其流量Common StockSEC:0001415889-25-019067:0
标准退出：2025年9月28日 (T+90)
250,000 股@ US$0.352100.0% 占其流量Common StockSEC:0001415889-25-008823:0
标准退出：2025年6月18日 (T+90)
79,687 股Common StockSEC:0001493152-24-026115:0
28,207 股Common StockSEC:0001493152-24-026108:0
173,000 股@ US$0.2016.7% 占其流量Common StockSEC:0001493152-24-022745:0
375,000 股@ US$0.4074.1% 占其流量Common StockSEC:0001493152-24-015572:0
10,625 股@ US$1.809.2% 占其流量Common StockSEC:0001493152-24-001134:0
8,289 股0Common StockSEC:0001209191-23-036073:0
15,777 股0Common StockSEC:0001209191-22-038598:0
4,700 股0Common StockSEC:0001209191-21-036684:0
11 条申报中的 11 条
About Schoeneck James A
James A. Schoeneck is a Director at FibroGen Inc. He contributes to the governance of the company by participating in defining its strategy and overseeing its activities. His expertise in the biopharmaceutical field is an asset for the company.
